By Dr. Liji Thomas, MD Stopping popular GLP-1 weight-loss drugs may reverse much of their benefit within a year, according to a large modeling analysis, raising questions about how long patients may ...

By Dr. Liji Thomas, MD New research suggests sleeping a little longer on weekends may help people who cut their sleep short ...

Background Remission and low-disease activity are recommended targets in systemic lupus erythematosus (SLE), yet many ...

AI-enhanced optical spectroscopy revolutionizes food quality monitoring with rapid, non-destructive analysis, ensuring safety and reducing waste in production.

Background Little is known about the association between direct pollen exposure and cognitive performance. The aim of our ...

A year after stopping taking weight-loss drugs such as Ozempic and Wegovy, people regain—on average—60% of their lost weight. But beyond this, their regained weight plateaus, with individuals managing ...

A year after stopping taking weight loss drugs such as Ozempic and Wegovy, people regain on average 60% of their lost weight – but beyond this, their weight regain plateaus, with individuals managing ...

This paper examines whether Chinese development finance is associated with faster progress toward Millennium Development Goal style targets in low- and middle-income countries. We combine AidData’s ...

A year after stopping taking weight loss drugs such as Ozempic and Wegovy, people regain on average 60% of their lost weight – but beyond this, their ...

Objective Geriatric patients often face issues related to polypharmacy and adverse drug events. Re-evaluating prescribed medications and considering deprescribing is critical. Medication discrepancies ...